Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
JIMD Reports|November 6, 2016
Incidence and Geographic Distribution of Succinic Semialdehyde Dehydrogenase (SSADH) DeficiencySavita Verma Attri, Pratibha Singhi, Natrujee Wiwattanadittakul, et al.
Frontiers in Genetics|July 16, 2024
Succinic semialdehyde dehydrogenase deficiency: a metabolic and genomic approach to diagnosisKevin E Glinton, Charul Gijavanekar, Abbhirami Rajagopal, et al.
FASEB Bioadvances|January 9, 2026
Impact of a GABA-Producing <i>Lactococcus lactis</i> on Microbiota and Mycobiota During CNS Inflammatory DemyelinationKristina Hill, Alexandra LaFollette, Trevor O Kirby, et al.
Metabolic Brain Disease|April 20, 2020
Correction to: Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomesTrevor Kirby, Dana C Walters, Madalyn Brown, et al.
Scientific Reports|February 27, 2015
Highly stable and sensitive fluorescent probes (LysoProbes) for lysosomal labeling and trackingNazmiye B Yapici, Yue Bi, Pengfei Li, et al.
Molecular Genetics and Metabolism|March 21, 2006
Clinical, cytogenetic and molecular characterization of a patient with combined succinic semialdehyde dehydrogenase deficiency and incomplete WAGR syndrome with obesityRonny Jung, Anita Rauch, Gajja S Salomons, et al.
Metabolic Brain Disease|March 16, 2020
Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomesTrevor Kirby, Dana C Walters, Madalyn Brown, et al.
Orphanet Journal of Rare Diseases|September 24, 2020
Novel biomarkers and age-related metabolite correlations in plasma and dried blood spots from patients with succinic semialdehyde dehydrogenase deficiencyTrevor Kirby, Dana C Walters, Xutong Shi, et al.
Journal of Inherited Metabolic Disease|April 8, 2006
Expression profiling reveals multiple myelin alterations in murine succinate semialdehyde dehydrogenase deficiencyElizabeth A Donarum, Dietrich A Stephan, Kay Larkin, et al.
Neurochemistry International|March 2, 2019
Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissuesDana C Walters, Erland Arning, Teodoro Bottiglieri, et al.
Pageof 15